Amneal Takes Control Of Kashiv Specialty In $100m+ Deal

Points To Value Of 505(b)(2) Pipeline And Complex Generics Experience

 
• By David Wallace
  
Handshake
Amneal has agreed a deal to take a 98% stake in Kashiv Specialty • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business